Renmatix, the U.S. leader in affordable cellulosic sugars headquartered in King of Prussia (Pennsylvania), announced a $14 million investment, led by Bill Gates. Industry demand for competitive alternatives to petro-derived molecules is gaining traction, despite recent market pressures. In the interest of expanding that supply, the Plantrose® process provides an enabling technology for profitable biorefineries. This investment in commercializing Plantrose will help drive towards the first wave of Renmatix licensees building Plantrose-enabled biorefineries in diverse global markets like Canada, India, Malaysia, the U.S. and elsewhere. In parallel, that activity will facilitate further market development in downstream bioproduct applications.
IL BIOECONOMISTA 